Search results
Showing: 10 of 310
Pharmacy First
Part VIC Redetermination (PDF: 286KB)
From 1 December 2023, the NHS Community Pharmacy Hypertension Case-Finding Advanced Service will relaunch and the NHS Pharmacy Contraception Service (PCS) will expand to include the initiation of oral…
Endorsement guidance
Your endorsement of NHS prescriptions plays a vital role in making sure we have the correct information for reimbursement and remuneration.
Electronic Prescription Service Guidance for Endorsement (PDF: 526KB)
NCSO endorsements
No NCSO…
Drug Tariff Updates for 2025/26
The following parts of the Drug Tariff have been updated to include details from the 2025/26 deal for contractors – further details are included in the Letter to Contractors.
Part I – Changes to the Payment Timetable to include earlier fee payments…
Drug Tariff Part IX information
The NHSBSA supports its staff to work in a hybrid home/office way. Part IX applications are most efficiently processed when they are submitted using email and we strongly encourage applicants to do this. Failure to do so may result in the…
Patient exemption checking: a guide for pharmacy teams in England
From 1 September 2021, the temporary signature suspension has been lifted. Patients, or their representatives, will again be required to sign the reverse of NHS prescription, dental and eye care forms, or tokens for prescriptions presented at the…
Medicines Delivery Service - cessation of service
We're delivering you the following message on behalf of NHS England and NHS Improvement.
The Advanced Service element of the Medicines Delivery Service (MDS) for self-isolating patients from pharmacies and dispensing doctors, ceased on 5 March 2022…
Prescription form overprint specifications
It’s important that the overprint specifications for prescriptions are followed so all forms are printed to a high standard. This makes it much easier for us to process the forms quickly to meet deadlines.
Guidance on current and out of date…
Retrospective Mebeverine 50mg/5ml price adjustment in NHS England and Wales from December 2022 to February 2023
This is an announcement on behalf of the Department of Health and Social Care.
The Department of Health and Social Care can confirm that the following product will have a redetermination due to late notification of a price increase, this will apply…
Drug Tariff update – Omeprazole oral suspension
This is an announcement on behalf of the Department of Health and Social Care
The Department of Health and Social Care and the National Assembly of Wales have retrospectively determined from September 2023:
the addition of Omeprazole 1mg/ml…
Drug Reimbursement - Riluzole and Rilutek
The Department of Health and Social Care (DHSC) have clarified that for Riluzole 50mg tablets (Part VIIIA Category A) and Rilutek 50mg tablets, contractors will be reimbursed the following for NHS prescriptions dispensed in January 2024…